MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 57 filers reported holding MEI PHARMA INC in Q3 2017. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $25,000 | -3.8% | 12,235 | +0.6% | 0.00% | – |
Q4 2017 | $26,000 | -29.7% | 12,161 | -11.1% | 0.00% | – |
Q3 2017 | $37,000 | +15.6% | 13,680 | +1.4% | 0.00% | – |
Q2 2017 | $32,000 | +45.5% | 13,487 | 0.0% | 0.00% | – |
Q1 2017 | $22,000 | +22.2% | 13,487 | +8.7% | 0.00% | – |
Q4 2016 | $18,000 | -18.2% | 12,407 | 0.0% | 0.00% | – |
Q3 2016 | $22,000 | +57.1% | 12,407 | +17.0% | 0.00% | – |
Q2 2016 | $14,000 | +7.7% | 10,600 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | – | 10,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
Sigma Planning Corp | 641,050 | $248,000 | 0.01% |